Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Joseph Fortuna"'
Publikováno v:
The Journal of Primary Prevention
Low uptake of routinely recommended adult immunizations is a public health concern. Using data from the peer-reviewed literature, government disease-surveillance programs, and the US Census, we developed a customizable model to estimate human and eco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdbd3cf383cb9f866fcaa659a1aac987
https://doi.org/10.1007/s10935-015-0394-3
https://doi.org/10.1007/s10935-015-0394-3
Autor:
Joseph Fortuna, T Warner Hudson
Publikováno v:
Journal of Occupational & Environmental Medicine. 50:924-934
International business travel to under-developed and developing countries has increased considerably over the past two decades. Most of these destinations are endemic to a variety of infectious diseases, many of which are associated with considerable
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c71c441d1b106187c0f12b42cf3c150
https://doi.org/10.1097/jom.0b013e318180804f
https://doi.org/10.1097/jom.0b013e318180804f
Autor:
Ronald Loeppke, Ted Scharf, Pamela A. Hymel, George W. Anstadt, Joseph Fortuna, Laura T. Pizzi, Catherine M. Baase, Doris L. Konicki, Jennifer H. Lofland
Publikováno v:
Journal of occupational and environmental medicine. 45(4)
An establishment of health-related productivity measurements and critical evaluation of health-related productivity tools is needed. An expert panel was created. A literature search was conducted to identify health-related productivity measurement to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::838e47f3ada3fa02f7bfe59949704540
https://pubmed.ncbi.nlm.nih.gov/14506334
https://pubmed.ncbi.nlm.nih.gov/14506334
Publikováno v:
Journal of Virus Eradication, Vol 6, Iss 2, Pp 61-69 (2020)
Introduction: ‘Repurposing’ existing drugs to treat COVID-19 is vital to reducing mortality and controlling the pandemic. Several promising drugs have been identified and are in various stages of clinical trials globally. If efficacy of these dru
Externí odkaz:
https://doaj.org/article/36a476bc119d4ab0ad06e9a2739ea36f
Autor:
Andrew Hill, Dzintars Gotham, Graham Cooke, Sanjay Bhagani, Isabelle Andrieux-Meyer, Jennifer Cohn, Joseph Fortunak
Publikováno v:
Journal of Virus Eradication, Vol 1, Iss 2, Pp 103-110 (2015)
Background: In 2013, an estimated 686,000 people died from hepatitis B virus (HBV) infection worldwide. Mass treatment programmes for hepatitis B will require very low drug costs. International treatment guidelines recommend first-line monotherapy wi
Externí odkaz:
https://doaj.org/article/7587cbe1c26a48f5af7092f4b923c934
Publikováno v:
Journal of Virus Eradication, Vol 2, Iss 1, Pp 2838-40 (2016)
Objectives: Novel treatments for hepatitis C demonstrate high cure rates, but current high prices can be a barrier to rapid global treatment scale-up. Generic competition can rapidly lower drug prices. Using data on exports of raw materials in 2015,
Externí odkaz:
https://doaj.org/article/f91372633fb44e2982d11d457dba5b2d
Autor:
Michael Lenning, Joseph Fortunato, Tai Le, Isaac Clark, Ang Sherpa, Soyeon Yi, Peter Hofsteen, Geethapriya Thamilarasu, Jingchun Yang, Xiaolei Xu, Huy-Dung Han, Tzung K. Hsiai, Hung Cao
Publikováno v:
Sensors, Vol 18, Iss 1, p 61 (2017)
Heart disease is the leading cause of mortality in the U.S. with approximately 610,000 people dying every year. Effective therapies for many cardiac diseases are lacking, largely due to an incomplete understanding of their genetic basis and underlyin
Externí odkaz:
https://doaj.org/article/f35249654af64425b928ecef985cf561
Conference
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.